logo-loader

Srax enjoys influx of cash after sale of SRAXmd of 52.5 million

Last updated: 15:04 17 Sep 2018 EDT, First published: 01:00 17 Sep 2018 EDT

SRAX (OTCQB:SCRI) CEO Chris Miglino joined Proactive Investors in San Francisco to talk about some major news about the company involving the sale of SRAXmd.

Miglino also talked about how the revenue from that sale will move the company forward as they get set to help to utilize blockchain technology for the BIGtoken platform

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

11 minutes ago